to discover new technology, new treatments, and new diseases in newborn screening
The Mission of the Newborn Screening Translational Research Network (NBSTRN) is to improve the health outcomes of newborns with genetic or congenital disorders by means of an infrastructure that allows investigators access to robust resources for newborn screening research.
The NBSTRN is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (contract #HHSN275201300011C). ©2012 American College of Medical Genetics and Genomics. All Rights Reserved.